Approval · Notice of Compliance 22038 · 2019
LOPERACAP: Notice of Compliance 22038
Issued April 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22038
- Date
- April 5, 2019
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to the product monograph and packaging labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOPERACAP | Not yet assigned | — |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB